Artificial intelligence and inflammatory bowel disease: practicalities and future prospects.

Journal: Frontline gastroenterology
Published Date: Dec 10, 2021

Abstract

Artificial intelligence (AI) is an emerging technology predicted to have significant applications in healthcare. This review highlights AI applications that impact the patient journey in inflammatory bowel disease (IBD), from genomics to endoscopic applications in disease classification, stratification and self-monitoring to risk stratification for personalised management. We discuss the practical AI applications currently in use while giving a balanced view of concerns and pitfalls and look to the future with the potential of where AI can provide significant value to the care of the patient with IBD.

Authors

  • Johanne Brooks-Warburton
    Department of Clinical Pharmacology and Biological Sciences, University of Hertfordshire, Hatfield, UK.
  • James Ashton
    Paediatric Gastroenterology, Southampton University Hospitals NHS Trust, Southampton, UK.
  • Anjan Dhar
    Gastroenterology, County Durham & Darlington NHS Foundation Trust, Bishop Auckland, UK.
  • Tony Tham
    Department of Gastroenterology, Ulster Hospital, Dundonald, UK.
  • Patrick B Allen
    Department of Gastroenterology, Ulster Hospital, Dundonald, UK.
  • Sami Hoque
    Department of Gastroenterology, Barts Health NHS Trust, London, UK.
  • Laurence B Lovat
    Division of Surgery & Interventional Science, University College London, London, UK.
  • Shaji Sebastian
    Department of Gastroenterology, Hull University Teaching Hospitals NHS Trust, Hull, UK.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals